A REAL-WORLD comparative study from a Moroccan tertiary centre has found that transperineal (TP) prostate biopsy offers similar cancer detection rates to the traditional transrectal (TR) approach, while reducing infectious complications and improving tissue sampling quality.
Prostate biopsy remains the gold standard for confirming prostate cancer in men with clinical suspicion. Although the TR route is widely used in routine practice, it is associated with a higher risk of infection and may inadequately sample anterior regions of the prostate. In contrast, the TP approach has been proposed as a safer alternative, but comparative real-world data remain limited in certain healthcare settings.
Real-World Comparison of Prostate Biopsy Techniques
In this retrospective analysis, 139 men undergoing…